Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated cytotoxicity assessment of natural killer cells by flow cytometry.

Frontiers in immunology·2026
Same author

An N-acetyltransferase-MAPK fusion protein modulates developmental reprogramming in Physcomitrium patens.

The New phytologist·2026
Same author

Using coffee waste as feedstock for continuous cultivation of Sulfolobus acidocaldarius.

Bioresource technology·2026
Same author

A novel cultivation strategy to recover NK cell cytotoxicity.

Frontiers in bioengineering and biotechnology·2026
Same author

Homogeneous shear distribution improves NK-92 cell cytotoxicity in a clinically relevant 2 L membrane-stirred bioreactor.

Frontiers in bioengineering and biotechnology·2026
Same author

Rapid development of a transferable Raman model using high-throughput cell culture for monitoring monoclonal antibody titer.

Biotechnology progress·2026

Related Experiment Video

Updated: Jan 2, 2026

Escherichia coli-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology
09:45

Escherichia coli-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology

Published on: February 25, 2019

37.1K

The Rocky Road From Fed-Batch to Continuous Processing With E. coli.

Julian Kopp1, Christoph Slouka2, Oliver Spadiut2

  • 1Christian Doppler Laboratory for Mechanistic and Physiological Methods for Improved Bioprocesses, Vienna, Austria.

Frontiers in Bioengineering and Biotechnology
|December 12, 2019
PubMed
Summary

Escherichia coli fed-batch processes are transitioning to continuous processing for improved biopharmaceutical production. Advances in strain engineering and process control enhance chemostat stability and yield.

Keywords:
E. coliburden reductioncontinuous processingfrom batch to continuous manufacturingprocess understanding

More Related Videos

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids
11:01

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids

Published on: September 25, 2016

8.1K
Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria
09:56

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria

Published on: October 13, 2021

4.5K

Related Experiment Videos

Last Updated: Jan 2, 2026

Escherichia coli-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology
09:45

Escherichia coli-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology

Published on: February 25, 2019

37.1K
Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids
11:01

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids

Published on: September 25, 2016

8.1K
Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria
09:56

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria

Published on: October 13, 2021

4.5K

Area of Science:

  • Biotechnology
  • Microbial Engineering
  • Bioprocess Engineering

Background:

  • Escherichia coli is a key host for biopharmaceutical production due to its rapid growth and scalability.
  • Industrial processes predominantly use fed-batch mode, but a shift towards continuous processing is emerging.
  • Continuous processing aims to enhance space-time yield and ensure consistent product quality attributes.

Purpose of the Study:

  • To review the current understanding of Escherichia coli fed-batch processes.
  • To explore the potential for transferring fed-batch knowledge to continuous processing.
  • To discuss advancements in continuous upstream and downstream processing of intracellular proteins.

Main Methods:

  • Review of historical and recent literature on Escherichia coli cultivation.
  • Analysis of improvements in strain engineering and promoter systems for chemostat processes.
  • Identification of critical process parameters and their impact on quality attributes.

Main Results:

  • Chemostat processing faced challenges with genetic instability and physiological issues historically.
  • Strain engineering and tunable promoters have significantly improved chemostat process viability.
  • Enhanced understanding of process parameters aids in controlling quality attributes and enables new applications like parallelization.

Conclusions:

  • Continuous processing offers advantages for biopharmaceutical production, moving beyond traditional fed-batch methods.
  • Despite challenges in controlling heterogeneous broths for long-term stability, advancements are paving the way.
  • The review highlights the progress and future potential of continuous Escherichia coli cultivation for biomanufacturing.